{"id":"W2312615589","doi":"10.1097/01.mib.0000456763.32133.67","title":"P-004 Anti-TNF (Infliximab) Plus mTOR Inhibitor (sirolimus) for Induction of Remission in Severe Steroid—Refractory Ulcerative Colitis","year":2014,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sirolimus; Ulcerative colitis; Infliximab; Gastroenterology; Mesalazine; Internal medicine; Proinflammatory cytokine; Inflammatory bowel disease; Immunology; Tumor necrosis factor alpha; Inflammation; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001127189,0.0003318599,0.0006007897,0.0002950775,0.0002733829,0.0001501509,0.0002294433,0.0003810421,0.001589235],"category_scores_gemma":[0.0001230826,0.00009577526,0.0003189554,0.0002043929,0.0001258227,0.0001607314,0.0001637588,0.0008630436,0.0006935089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001383233,"about_ca_system_score_gemma":0.0001468712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004333162,"about_ca_topic_score_gemma":0.0008925586,"domain_scores_codex":[0.9999441,0.00001300523,0.000007573161,0.000009394002,0.0000103569,0.00001550489],"domain_scores_gemma":[0.9999551,0.000006007876,0.000006729503,0.000003024311,0.000004579998,0.00002475926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04757025,0.009327346,0.008944381,0.001871889,0.0006344491,0.03451627,0.0003793827,0.001049792,0.2034191,0.0009072804,0.01381011,0.6775698],"study_design_scores_gemma":[0.06061864,0.2762823,0.2418844,0.000618553,0.001103439,0.1133072,0.0003704263,0.008519898,0.09148885,0.001163969,0.2044574,0.0001849341],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.957276,0.02564192,0.002330915,0.001455881,0.0004417905,0.0005830461,0.0003538725,0.0004713854,0.01144521],"genre_scores_gemma":[0.985505,0.006014796,0.001794799,0.0008378037,0.0001966733,0.0001735044,0.0004846568,0.00002169587,0.004970943],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.001589235,"threshold_uncertainty_score":0.005316556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00847836705292002,"score_gpt":0.240034456667535,"score_spread":0.231556089614615,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}